Details of the Drug
General Information of Drug (ID: DMDMJZ2)
| Drug Name |
IGN-312
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | Glycoengineered IGN-311 derived MAb, Aphton; Glycoengineered IGN-311 derived MAb, Igeneon; Anti-Lewis Y mAb (Potelligent, cancer immunotherapy), Igeneon | ||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
